SLC11A2 and metabolic dysfunction-associated steatohepatitis: Hoki T et al. discovered that hepatic iron accumulation in NASH patients is mainly due to the increased expression of divalent metal transporter 1 (DMT1) secreted by the Ca-co-2/TC7 cell lines, activating iron-regulated protein (IRP) [101].